HER-1 peptide vaccine (Ohio State University/Imugene)

N/A

Report date: 2025/01/26 18:29:12

Base Information

Drug NameHER-1 peptide vaccine (Ohio State University/Imugene)
Drug Alias NameEGFR peptide vaccine (Ohio State University/Imugene)
ClassificationVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionEpidermal growth factor receptor erbB1 modulators
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Ohio State University
China Registration ClassN/A

Develop Information

Active CompaniesImugene Ltd
Inactive CompaniesThe Ohio State University
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A